{"count": 1, "results": [{"_id": "17563269", "pmid": 17563269, "title": "Metformin/rosiglitazone combination pill (Avandamet) for the treatment of patients with Type 2 diabetes.", "journal": "Expert Opin Pharmacother", "authors": ["Smiley D", "Umpierrez G"], "date": "2007-06-01T00:00:00Z", "doi": "10.1517/14656566.8.9.1353", "meta_date_publication": "2007 Jun", "meta_volume": "8", "meta_issue": "9", "meta_pages": "1353-64", "score": 50068.824, "text_hl": "As @DISEASE_Insulin_Resistance @DISEASE_MESH:D007333 @@@insulin resistance@@@ is a pathophysiologic cornerstone of @<m>DISEASE_Diabetes_Mellitus</m> @DISEASE_MESH:D003920 @@@diabetes@@@ and @DISEASE_Cardiovascular_Diseases @DISEASE_MESH:D002318 @@@cardiovascular disease@@@, the use of @<m>CHEMICAL_rosiglitazone_metformin_combination</m> @CHEMICAL_MESH:C471074 @@@Avandamet@@@ represents an optimal approach to the treatment of @<m>DISEASE_Diabetes_Mellitus</m> @DISEASE_MESH:D003920 @@@diabetes@@@. ", "citations": {"NLM": "Smiley D, Umpierrez G. Metformin/rosiglitazone combination pill (Avandamet) for the treatment of patients with Type 2 diabetes. Expert Opin Pharmacother. 2007 Jun;8(9):1353-64. PMID: 17563269", "BibTeX": "@article{17563269, title={Metformin/rosiglitazone combination pill (Avandamet) for the treatment of patients with Type 2 diabetes.}, author={Smiley D and Umpierrez G}, journal={Expert Opin Pharmacother}, volume={8}, number={9}, pages={1353-64}}"}}]}